Back
HFA Premium Access

Actual condition survey of terminal illness in the advanced heart failure: symptoms and drug utilization during the last two weeks of life

Session: Poster Session 2 - Advanced heart failure
Topic: Advance heart failure
Speaker: Doctor T. Miyata (Himeji, JP)
Event: HEART FAILURE 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Taishi Miyata

Himeji Cardiovascular Center, Himeji (Japan)
0 follower

7 more presentations in this session

Hemodynamic effects of ivabradine in patients with advanced heart failure

Speaker: Doctor R. Tschierschke (Mannheim, DE)

Access
Abstract
Slides
Like
Thumbnail

Anti-HLA antibodies prevalence in an advanced heart failure population

Speaker: Doctor A. Ayesta Lopez (Madrid, ES)

Access
Abstract
Like
Thumbnail

Genetic variations in end-stage dilated cardiomyopathy patients

Speaker: Assistant Professor E. Martins (Porto, PT)

Access
Abstract
Like
Thumbnail

Transition between early and late experience with continuous intravenous morphine for relief of dyspnea in patients with advanced heart failure

Speaker: Doctor S. Oishi (Himeji, JP)

Access
Abstract
Like
Thumbnail

Effect of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular deaths in patients with and without diabetes mellitus in advanced chronic heart failure

Speaker: Professor D. Ural (Istanbul, TR)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Advanced heart failure

Speakers: Doctor T. Miyata, Doctor R. Tschierschke, Doctor A. Ayesta Lopez, Assistant Professor E. Martins, Doctor S. Oishi...
Access
Like
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources